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Abstract
All treatments for obesity, including dietary restriction of carbohydrates, have a goal of reducing
the storage of fat in adipocytes. The chief enzyme responsible for the mobilization of FFA from
adipose tissue, i.e., lipolysis, is thought to be hormone-sensitive lipase (HSL). Studies of HSL
knockouts have provided important insights into the functional significance of HSL and into adipose
metabolism in general. Studies have provided evidence that HSL, though possessing triacylglycerol
lipase activity, appears to be the rate-limiting enzyme for cholesteryl ester and diacylglycerol
hydrolysis in adipose tissue and is essential for complete hormone stimulated lipolysis, but other
triacylglycerol lipases are important in mediating triacylglycerol hydrolysis in lipolysis. HSL
knockouts are resistant to both high fat diet-induced and genetic obesity, displaying reduced
quantities of white with increased amounts of brown adipose tissue, increased numbers of adipose
macrophages, and have multiple alterations in the expression of genes involved in adipose
differentiation, including transcription factors, markers of adipocyte differentiation, and enzymes of
fatty acid and triglyceride synthesis. With disruption of lipolysis by removal of HSL, there is a drastic
reduction in lipogenesis and alteration in adipose metabolism.
Introduction
Free fatty acids (FFA) are a major energy source for most
tissues in mammals. Circulating FFA in plasma are prima-
rily derived from adipose tissue, which is the main repos-
itory for the storage of triacylglycerol. All treatments for
obesity, including dietary restriction of carbohydrates,
have a goal of reducing the storage of fat in adipocytes.
The chief enzyme responsible for the mobilization of FFA
from adipose tissue, i.e., lipolysis, was thought to be hor-
mone-sensitive lipase (HSL). This review addresses some
aspects of the organization of components of fat metabo-
lism in the adipocyte, lipolysis and lipogenesis, and how
genetic manipulation of the pathway of lipolysis affects
fat metabolism in the adipocyte.
Properties of HSL
HSL is an intracellular, neutral lipase that has broad sub-
strate specificity, catalyzing the hydrolysis of triacylglyc-
erol, diacylglycerol, monoacylglycerol, and cholesteryl
esters, as well as retinyl esters; however, it possesses no
phospholipase activity [1]. Its activity against diacylglyc-
erol is about 10-fold and 5-fold higher than its activity
against triacylglycerol and monoacylglycerol, respectively,
whereas its activity against cholesteryl esters is about twice
its activity toward triacylglycerol. The hydrolytic activity of
HSL against triacylglycerol and cholesteryl esters, but not
against diacylglycerol, is stimulated by phosphorylation
mediated primarily by protein kinase A (PKA) [1].
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Lipolysis
The regulation of lipolysis is complex and, although not
completely understood, involves multiple mechanisms,
including lipolytic (β-adrenergic agonists, ACTH, etc.)
and anti-lipolytic (insulin, adenosine, etc.) hormones and
their cognate receptors and signaling pathways, particu-
larly involving cyclic AMP and PKA. Current working
models for the mechanisms underlying lipolysis have
focused on steps downstream of hormone receptors and
signaling cascades, concentrating on lipid droplet-associ-
ated proteins, such as perilipins, and lipases, such as HSL
and others, that appear to play vital roles in lipolysis [1].
In a simplified view (Figure 1), these models suggest that,
under basal, unstimulated conditions, perilipin decorates
the surface of the lipid droplet, protecting the lipid drop-
let from hydrolysis by HSL, which is primarily located
within the cytosol. Upon lipolytic stimulation, PKA is
activated, resulting in the phosphorylation of both perili-
pin and HSL. Phosphorylation of perilipin then facilitates
the translocation of HSL from the cytosol to the lipid
droplet, where hydrolysis of triacylglycerol and lipolysis
can proceed.
Studies of mice where HSL has been inactivated by
homologous recombination have provided important
insights into the functional significance of HSL and into
adipose metabolism in general. HSL null mice have a nor-
mal physical appearance and are nonobese, lacking an
apparent phenotype, with the exception that homozygous
males have severe oligo- or azospermia and are infertile
[2]. However, careful examination of adipocytes does
reveal abnormalities. There are histological changes in
adipose tissue. Brown adipose tissue (BAT) displays
increased cell size and white adipose tissue (WAT) dis-
plays an increased heterogeneity of cell size, with both
larger and smaller cells being more prevalent [2,3]. Exam-
ination of enzyme activity showed the complete absence
of neutral cholesteryl ester hydrolase activity in adipose
tissue, both WAT and BAT. Moreover, examination of
other tissues where HSL is expressed, for instance adrenal,
testis, ovary, and heart, showed the almost complete
absence of neutral cholesteryl ester hydrolase activity
[2,4]. Thus, HSL is responsible for all, or practically all, of
the neutral cholesteryl ester hydrolase activity in adipose
and steroidogenic tissues. In contrast, triacylglycerol
lipase activity in WAT was reduced by only 40–50% and
triacylglycerol lipase activity in BAT was similar to wild
type mice [2,3,5], suggesting the existence of one or more
other neutral triacylglycerol lipases. Measurement of
plasma concentrations of glycerol and FFA showed a 40–
60% reduction in circulating levels under unstimulated
conditions, whereas there was a small, but markedly
Cartoon model of lipolysis Figure 1
Cartoon model of lipolysis. Under basal conditions perilipin is localized to the lipid droplet, along with other droplet asso-
ciated proteins, such as ATGL (adipose triglyceride lipase), whereas HSL is primarily localized in the cytosol along with other 
cytosolic proteins such as FABP (fatty acid binding protein). Following lipolytic stimulation, PKA is activated, resulting in the 
phosphorylation of perilipin and HSL. This is associated with the translocation of HSL from the cytosol to the lipid droplet 
where hydrolysis of the triacylglycerol lipid droplet occurs.Nutrition & Metabolism 2006, 3:12 http://www.nutritionandmetabolism.com/content/3/1/12
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attenuated, increase following isoproterenol injection,
supporting an important, but not exclusive, role for HSL
in lipolysis. In vitro studies of adipose cells isolated from
HSL null mice recapitulated the in vivo findings for the
most part; there was a marked defect or complete absence
of catecholamine-stimulated glycerol release in adipose
cells from HSL null mice, whereas catecholamine-stimu-
lated FFA release was still observed, but attenuated
[2,3,5,6]. This apparent discrepancy in the release of glyc-
erol and FFA from adipose cells of HSL null mice has been
clarified by the observation that diacylglycerol content
increased markedly in adipose tissue of HSL null mice [5].
In both white and brown adipose tissue from HSL null
mice, catecholamine-stimulation caused the release of
small amounts of FFA without any stimulated glycerol
release, and a marked accumulation of diacylglycerol [5].
These results are consistent with the known substrate spe-
cificity of HSL being 10-fold higher against diacylglycerol
than triacylglycerol. Indeed, direct measurement of dia-
cylglycerol lipase activity showed that activity was reduced
>95% in adipose tissue of HSL null mice, whereas diacylg-
lycerol lipase activity was unaltered in muscle and liver
[7]. Therefore, HSL, though possessing triacylglycerol
lipase activity, appears to be the rate-limiting enzyme for
cholesteryl ester and diacylglycerol hydrolysis in adipose
tissue and is essential for complete hormone stimulated
lipolysis.
Lipases in adipocytes
The presence of residual triacylglycerol lipase activity in
adipose tissue of HSL null mice has led to the search for
other lipases responsible for the maintenance of the
mobilization of FFA from fat. Using functional proteom-
ics and oleic acid-linked agarose chromatography, Soni et
al [8] identified carboxylesterase 3, also known as triacylg-
lycerol hydrolase, as an abundant lipase in adipose tissue
that continues to be expressed in HSL null mice. Using an
in silico approach, Zimmermann et al [9] identified a pro-
tein that possessed lipase activity and was highly
expressed in adipose tissue which they termed adipose
triglyceride lipase (ATGL). ATGL had been identified by
other authors, who termed it desnutrin [10] and calcium
independent phospholipase A2ζ [10,11]. ATGL contains a
patatin-like sequence and has homology with several
other patatin-like family members such as adiponutrin
and GS2 or iPLA2η [11]. Based on immunoprecipitation
of ATGL from adipose tissue homogenates, ATGL was
reported to account for 60–70% of the neutral triacylglyc-
erol lipase activity in both wild-type and HSL null mice
[9]. However, it is apparent that there are multiple lipases
in adipose tissue since 23 different proteins that poten-
tially possess lipolytic or esterolytic activity in mouse adi-
pose tissue have been identified using a proteomics
approach that took advantage of fluorescent tags that
mimic lipid substrates [12]. In unpublished work we have
recently examined the relative expression levels of 11 of
the lipase/esterases in WAT using quantitative RT-PCR
analysis. The proteins examined are: HSL, ATGL, adiponu-
trin, triacylglycerol hydrolase, α/β hydrolase containing
mRNA 5 (also known as CGI-58) and 11 (also known as
Beuren-Williams Syndrome Critical Region 21), acylpep-
tide hydrolase, esterase 1, esterase D, carboxylesterase
ML1, and membrane-associated calcium-independent
phospholipase A2γ. We found the following relative
expression levels in normal mouse WAT in descending
order of abundance: ATGL, HSL, triacylglycerol hydrolase,
adiponutrin, membrane-associated calcium-independent
phospholipase A2γ, esterase D, CGI-58, carboxylesterase
ML1, acylpeptide hydrolase, Beuren-Williams Syndrome
Critical Region 21, and esterase 1. Since the residual basal
triacylglycerol lipase activity in WAT of HSL null mice
indicates the existence of other lipase(s), we examined the
expression levels of these other 10 lipase/esterases in WAT
of HSL null mice. Surprisingly, almost all of the 10 lipase/
esterases showed decreased levels of expression when
compared with wild-type mice, with ATGL and triacylglyc-
erol hydrolase reduced to only 30% of that of wild-type
mice. Thus, multiple proteins with lipase/esterase activity
are expressed in WAT and the absence of HSL does not
result in a compensatory increase in the mRNA of any of
these proteins, but rather in a global decrease in the
expression of all lipases/esterases.
HSL KO mice are resistant to obesity
When the influence of HSL on the development of dietary
induced obesity was examined by feeding high fat diets
for 15 weeks, 20–26% lower weights were observed in
male and female, respectively, HSL null mice compared
with control [13]. This occurred even though there was a
higher food intake per body weight in HSL null mice and
without any evidence of lipid malabsorption. There was
increased fasting induced weight loss and higher core
body temperatures in HSL null mice, consistent with an
increase in energy expenditure. Even though total body
weights were similar on a normal chow diet, total WAT
mass was reduced in HSL null mice compared to control
and this difference was exaggerated on a high fat diet, with
total WAT weight more than 70% lower in HSL null mice
than in control. In contrast to WAT, interscapular BAT was
larger in HSL null mice than in control. In addition to
resistance to diet-induced obesity, the absence of HSL also
protects against genetic obesity, based on the observation
that mice homozygous for both HSL and leptin deficiency
(ob/ob) are 26% lighter than ob/ob  mice and this is
reflected by a reduction in WAT mass [14]. The greater
amount of heterogeneity of cell size in HSL null mice is
exaggerated in mice with combined HSL and leptin defi-
ciency, with a marked increase in small, lipid-devoid cells
that appear to have characteristics of pre-adipocytes [14].Nutrition & Metabolism 2006, 3:12 http://www.nutritionandmetabolism.com/content/3/1/12
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Altered adipose gene expression in HSL KO 
mice
In addition to accumulation of diacylglycerol in tissues
noted above, cholesterol content in adipose tissues was
increased in HSL null mice and this was accentuated by
high fat feeding where cholesterol content was 5-fold
higher in HSL null mice [13]. Besides changes in histology
and lipid content, HSL deficiency has multiple effects on
adipose metabolism. Levels of mRNA expression of perox-
isome proliferator-activated receptor γ (PPARγ) and
CCAAT/enhancer binding protein α (C/EBPα), two of the
major transcription factors for adipogenesis [15,16], were
suppressed 40–70% in WAT of HSL null mice. Similarly,
PPARα levels were also diminished ~70% in WAT of HSL
null mice.
In parallel to the suppression of transcription factors,
mRNA expression of markers of adipose differentiation
such as adiponectin, leptin, resistin and adipsin, which
are all humoral factors derived from adipose tissue, were
decreased 60–90% [13]. In contrast, expression of TNFα
was up-regulated 2–3-fold in WAT and 5–10-fold in BAT
of HSL null mice compared with control. Again consistent
with the reduction in adipogenic transcription factors, all
genes associated with fatty acid and triglyceride metabo-
lism, such as adipocyte fatty acid binding protein, perili-
pin, lipoprotein lipase, glycerol-3-phosphate
acyltransferase (GPAT), mitochondrial GPAT, acetyl-CoA
carboxylase, fatty acid synthase, acyl-CoA synthetase, acyl-
CoA:diacylglycerol acyltransferase 1 (DGAT-1), DGAT-2,
ATP citrate lyase, were reduced in WAT of HSL null mice
on either a normal chow or high fat diet [13,17]. These
alterations in gene expression resulted in a marked
decrease in fatty acid esterification pathways and in the
synthesis of neutral lipids and glycerol-phospholipids in
WAT of HSL null mice [17]. Thus, with disruption of lipol-
ysis by removal of HSL, there is a drastic reduction in lipo-
genesis, which could allow a more efficient export of fatty
acids released by lipolysis out of the cell.
In accordance with the down-regulation of adipogenic
transcription factors, expression of insulin receptor, insu-
lin receptor substrate-1 and glucose transporter 4 mRNA
was decreased 30–80% in WAT of HSL null mice com-
pared with control [13]. However, examination of genes
involved with cholesterol metabolism revealed that
expression of 3-hydroxy-3-methylglutaryl-CoA (HMG
CoA) reductase, the rate-limiting enzyme for cholesterol
synthesis, was up-regulated ~2-fold; whereas, HMG CoA
synthase-1, an enzyme upstream of HMG CoA reductase,
was down-regulated 50–70% in WAT of HSL null mice
[13]. Surprisingly, expression of acyl-CoA:cholesterol
acyltransferase 1, the enzyme that mediates the esterifica-
tion of cholesterol to cellular cholesteryl esters was
increased 2–4-fold in WAT and 5–8-fold in BAT. Expres-
sion levels of the lipogenic transcription factor sterol reg-
ulatory element binding protein-1c (SREBP-1c) were
suppressed 50–75%, whereas expression of SREBP-2,
which controls cholesterol synthesis and uptake, was up-
regulated 2-fold. In parallel to the changes in SREBP-2,
uncoupling protein 2 was increased 3–4-fold in BAT in
HSL null mice [13].
Insulin and glucose metabolism in HSL KO mice
The effects of HSL deficiency on insulin and glucose
metabolism is controversial in that several papers have
been published that report conflicting results. For
instance, overall insulin sensitivity in HSL null mice has
been reported to be decreased by some authors [7] and
normal by other authors [18,19]. Hepatic insulin sensitiv-
ity has been reported to be increased [18,19], whereas
insulin sensitivity in adipose tissue and in muscle has
been reported to be reduced [7,17] or normal [18,19].
Likewise, insulin secretion in HSL null mice has been
reported to be either normal [7,20] or reduced [21,22].
The bases for these differences in results are not readily
apparent, but may be due to differences in the genetic
background on which the HSL null mice have been exam-
ined or may depend on whether the studies have been
conducted in vitro or in vivo.
Macrophages in adipose tissue of HSL KO mice
Recent observations that there is increased macrophage
infiltration into WAT in obesity have been extended to
HSL null mice [23]. Even though there is decreased WAT
mass in HSL null mice as opposed to the increase seen in
obesity, there is a greater prevalence of hypertrophied adi-
pocytes in HSL null mice. Recent studies have observed
that, in parallel to adipocyte hypertrophy, there is an
increase in macrophages located in crown-like structures
surrounding adipocytes with the macrophages scavenging
adipocyte-free lipid droplets released from cells undergo-
ing necrotic-like cell death [23]. Thus, the greater numbers
of macrophages in WAT in HSL null mice could contrib-
ute to the increase in TNFα and some of the other changes
in adipocyte function observed.
Conclusion
HSL null mice display defective lipolysis due to dimin-
ished expression of lipases and lipid droplet-associated
proteins, reduced quantities of WAT with increased
amounts of BAT, increased numbers of macrophages in
WAT, are resistant to high-fat diet induced obesity second-
ary to an apparent increase in thermogenesis and energy
expenditure, and have multiple alterations in the expres-
sion of genes involved in adipose differentiation, includ-
ing transcription factors, markers of adipocyte
differentiation, and enzymes of fatty acid and triglyceride
synthesis. Although the mechanisms responsible for these
alterations are not clear, at least three possibilities in addi-Nutrition & Metabolism 2006, 3:12 http://www.nutritionandmetabolism.com/content/3/1/12
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Cartoon models of potential mechanisms underlying the altered adipocyte metabolism in HSL KO mice Figure 2
Cartoon models of potential mechanisms underlying the altered adipocyte metabolism in HSL KO mice. Panel 
A. Since HSL is the key diacylglycerol lipase in adipose tissue, diacylglycerol accumulates in HSL null mice leading to the activa-
tion of protein kinase C family members and their downstream targets such as MAPK, thus affecting cell proliferation, apopto-
sis, and differentiation. Panel B. Since HSL is the key neutral cholesteryl ester hydrolase in adipose tissue, a regulatory pool of 
free cholesterol might be depleted in HSL null mice leading to an increase in the transcription factor SREBP2 (sterol regulatory 
element binding protein 2) and a subsequent up-regulation of its transcriptional targets such as UCP2 (uncoupling protein 2). 
Panel C. Since HSL mediates the mobilization of fatty acids, the release of specific fatty acids by HSL might be required for the 
production of ligands that are preferentially utilized by PPARγ. A relative lack of PPARγ ligands might suppress the mutual acti-
vation of PPARγ and C/EBPα, the 2 most important transcription factors required for adipocyte differentiation.Nutrition & Metabolism 2006, 3:12 http://www.nutritionandmetabolism.com/content/3/1/12
Page 6 of 7
(page number not for citation purposes)
tion to infiltration of macrophages might explain these
findings. First, since HSL is apparently the primary dia-
cylglycerol lipase in adipose tissue, the accumulation of
diacylglycerol in WAT of HSL null mice might interfere
with normal adipocyte differentiation or function
through the activation of protein kinase C family mem-
bers and their downstream targets, which are known to
affect cell proliferation, apoptosis, and differentiation
(Figure 2A). Second, since HSL appears to be the only neu-
tral cholesteryl ester hydrolase in adipose tissue, the ina-
bility to hydrolyze cholesteryl esters might reduce
regulatory pools of cellular unesterified cholesterol (Fig-
ure 2B), which has been suggested to be a sensor linking
adipose cell size to metabolism [24]. This might lead to an
up-regulation of SREBP2 and a subsequent increase in
UCP2. Third, since HSL mediates the mobilization of fatty
acids, the release of specific fatty acids by HSL might be
required for the production of ligands that are preferen-
tially utilized by PPARγ (Figure 2C). A relative lack of
PPARγ ligands due to the absence of HSL might suppress
the mutual activation of PPARγ and C/EBPα, thus affect-
ing adipocyte differentiation. Whichever the molecular
basis for these alterations, HSL null mice have proven to
be extremely useful in helping to elucidate the pathways
of lipolysis and an important model for studying adipose
cell metabolism.
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